Sourcing Nabota is one part of the equation — handling it correctly once it arrives at your clinic is the other. Reconstitution errors, storage lapses, and inconsistent dosing are among the most common (and most avoidable) issues clinics run into with any botulinum toxin product, Nabota included. This guide covers the practical handling side: dilution, standard dosage ranges, storage requirements, and how Nabota compares to other neurotoxins on the market.
This is general commercial and product-handling information, not medical or prescribing guidance. Actual reconstitution, dosing, and administration must follow the product's official labeling for your market and the judgment of a licensed, trained injector.
Reconstitution & Dilution
Nabota is supplied as a lyophilized (freeze-dried) powder in 100-unit vials and must be reconstituted with preservative-free 0.9% sterile saline before use. Dilution volume determines the concentration per injection point — clinics typically select a dilution based on treatment area and injector preference.
| Saline Added (0.9% NaCl) | Resulting Concentration | Common Use Case |
|---|---|---|
| 1.0 mL | 10 U / 0.1 mL | More concentrated, precise small-area work |
| 2.0 mL | 5 U / 0.1 mL | Common mid-range dilution |
| 2.5 mL | 4 U / 0.1 mL | Widely used standard dilution |
| 4.0 mL | 2.5 U / 0.1 mL | Broader spread, larger treatment areas |
Reconstitute gently — swirl rather than shake, to avoid denaturing the protein. Once reconstituted, the solution should be visually clear and colorless; discard it if it looks cloudy or discolored.
Standard Dosage by Treatment Area
The ranges below reflect commonly cited industry dosing patterns for glabellar and upper-face treatment. They are a reference point, not a prescription — actual units depend on muscle mass, patient anatomy, and the injector's clinical assessment.
| Treatment Area | Typical Range | Injection Points |
|---|---|---|
| Glabellar lines (frown lines) | 16–24 U | 4–5 points |
| Forehead lines | 8–20 U | 4–6 points |
| Crow's feet (lateral canthal lines) | 12–24 U total | 3 points per side |
| Masseter (jawline slimming) | 20–30 U per side | 2–3 points per side |
Storage & Shelf Life
| State | Storage Condition | Typical Window |
|---|---|---|
| Unopened vial | Refrigerated, 2–8°C | Until labeled expiry date |
| In transit (cold chain) | Continuous 2–8°C with data logger | Duration of shipment |
| Reconstituted vial | Refrigerated, 2–8°C | Use within 24 hours; discard unused portion |
Never freeze Nabota, reconstituted or not — freezing degrades the protein structure. If a shipment's temperature data logger shows any excursion outside the validated cold-chain range, treat the batch as compromised and do not administer it; contact your supplier with the logger data before using or reordering.
How Nabota Compares to Other Neurotoxins
| Attribute | Nabota | Typical Botulinum Toxin Type A |
|---|---|---|
| Active ingredient | HI-PURE™ purified botulinum toxin type A | Botulinum toxin type A (varies by manufacturer purification method) |
| Onset | Typically within 2–5 days | Generally comparable, 2–7 days |
| Duration | Commonly cited at 3–4 months | Generally comparable, 3–4 months |
| Unit conversion | Approximately 1:1 with onabotulinumtoxinA in most clinical practice | Varies by product — always confirm before switching |
Unit-for-unit comparisons between botulinum toxin brands are commonly used as a starting reference in clinical practice, but they are not interchangeable without adjustment — injectors switching between products should treat the first session as a recalibration, not a like-for-like swap.
Handling Best Practices for Clinics
- Log the cold chain on arrival. Check the shipment's temperature data logger before accepting delivery, not after storage.
- First in, first out. Rotate stock so vials closer to their expiry date are used first.
- Label reconstituted vials with date and time. The 24-hour clock starts at reconstitution, not at first use.
- Keep batch and lot records. Match lot numbers to patient records for traceability, especially for adverse event reporting.
- Don't shake. Swirl gently to avoid denaturing the protein during reconstitution.
Frequently Asked Questions
Can Nabota be refrozen if it's not used?
No. Nabota should never be frozen at any stage, reconstituted or not. If a vial has been reconstituted and not used within the recommended window, it should be discarded rather than refrozen for later use.
Is the dosage the same for every patient?
No. The ranges in this guide are commonly cited reference points, not fixed prescriptions. Actual dosing depends on the patient's muscle mass, treatment goals, and the injector's clinical judgment.
How do I know my cold chain wasn't broken in transit?
A validated cold-chain shipment should include a temperature data logger covering the full transit window. Check it against the vial's validated storage range before accepting or using the batch.
Sourcing Nabota Through HolyPath
HolyPath supplies Nabota to licensed clinics and distributors internationally, with validated cold-chain shipping and full batch documentation on every order. If you're setting up a new import route, a trial order is the fastest way to confirm your cold chain, documentation, and customs process hold up before you commit to volume.
Request a wholesale quotation →
📧 info@holypathglobal.com | 📞 +82 10 8164 1410 | Mon–Fri 9AM–7PM KST
This article is intended for licensed medical professionals, clinics, and authorized distributors. It is general commercial and handling information, not medical, prescribing, or regulatory advice. Reconstitution, dosing, and administration must follow the product's official labeling and the judgment of a licensed, trained injector. Verify import and registration requirements with your national regulatory authority before ordering.